Previous Close | 63.85 |
Open | 64.55 |
Bid | 64.86 x 800 |
Ask | 64.98 x 300 |
Day's Range | 63.51 - 67.58 |
52 Week Range | 8.28 - 99.41 |
Volume | |
Avg. Volume | 6,455,517 |
Market Cap | 7.156B |
Beta (5Y Monthly) | 1.10 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.91 |
Earnings Date | Apr 24, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 113.80 |
A look at three stocks where technical analysis can help and the TAZR service.
Viking Therapeutics, Inc. (VKTX) concluded the recent trading session at $63.42, signifying a -1.93% move from its prior day's close.
Devoid of marketed drugs, investors will focus on Viking Therapeutics' (VKTX) pipeline updates when it reports first-quarter earnings results.